Skip to the page

Data / Drug companies / Cosma Spa

Cosma Spa: 15 products in the FDA NDC directory, labeler code 51604

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Cosma Spa (labeler code 51604) lists 15 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 22, 2021.

The request: Watch Cosma Spa (FDA labeler code 51604): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
51604
Products in commercial distribution
15
Packages
15
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
October 11, 2000
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients1066.7%
Bulk ingredients for compounding533.3%

Products by type

TypeProductsShare
Bulk ingredients15100%

Dosage forms

Dosage formProductsShare
Powder15100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Proglumide51604-1092PowderBulk ingredientsJune 22, 2021
Amisulpride51604-1156PowderBulk ingredients for compoundingMay 29, 2019
Cetirizine dihydrochloride51604-0021PowderBulk ingredients for compoundingNovember 26, 2018
Ketoprofen51604-0011PowderBulk ingredients for compoundingNovember 26, 2018
Levomilnacipran hydrochloride51604-1183PowderBulk ingredients for compoundingNovember 12, 2018
Diclofenac hydroxy ethyl pyrrolidine51604-1159PowderBulk ingredientsJuly 24, 2013
Ranolazine51604-1154PowderBulk ingredientsAugust 3, 2012
Torsemide51604-0020PowderBulk ingredientsOctober 14, 2009
Labetalol hydrochloride51604-0017PowderBulk ingredientsOctober 14, 2009
Pyrantel pamoate51604-0013PowderBulk ingredientsOctober 14, 2009
Metoclopramide hydrochloride51604-0005PowderBulk ingredientsOctober 14, 2009
Hydroxyzine pamoate51604-0004PowderBulk ingredientsOctober 14, 2009
Hydroxyzine hydrochloride51604-0003PowderBulk ingredientsOctober 14, 2009
Propranolol hydrochloride51604-0002PowderBulk ingredientsOctober 14, 2009
Torsemide51604-0018PowderBulk ingredients for compoundingOctober 11, 2000

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.